Global Single-Use Bioprocessing Market Size By Product (Containers, Media bags), By Workflow (Upstream, Fermentation, Downstream), By End Use (Biopharmaceutical Manufacturer, Academic & Clinical Research Institutes), By Geographic Scope And Forecast

Single-Use Bioprocessing Market Size And Forecast

Single-Use Bioprocessing Market size was valued at USD 11.05 Billion in 2021 and is projected to reach USD 15.1 Billion by 2030, growing at a CAGR of 18.02% from 2022 to 2030. Increasing demand for biopharmaceuticals, high energy efficiency, low tide usage, less floor space requirement, very low risk of product cross-contamination, and faster to implement are the key drivers for the expansion of the global single-use bioprocessing market. The global demand for biopharmaceuticals is rapidly increasing. Many leading pharmaceutical companies are actively investing in biopharmaceuticals and related products. One of the most significant drivers of this demanding hike is the growing elderly population and the prevalence of chronic conditions. Hence, throughout the forecast period, the global single-use bioprocessing market is expected to grow significantly faster.

Global Single-Use Bioprocessing Market Definition

Various bioprocessing techniques employ single-use media bags and containers. Additionally, the biopharmaceutical and biomanufacturing sectors frequently employ single-use containers for crucial liquid handling applications. Monoclonal antibodies (mAb) are produced using single-use bioprocessing technologies; as a result, this sector dominates the global single-use bioprocessing market. The usage of disposables has increased dramatically in the bioprocessing sector as a result of benefits provided by single-use technology (SUT), such as a considerable decrease in capital cost and facility building time. The market for single-use bioprocessing has grown by double digits as a result of this.

The expanding elderly population throughout the globe is likely to boost the market expansion in the following years. According to the United Nations, by 2050, it is predicted that roughly 1.5 billion of the global population would be of or over the age of 65 years. The senior population is more susceptible to chronic illnesses, thus there will be a significant increase in demand and consumption of biopharmaceutical drugs, which will fuel the expansion of the global single-use bioprocessing market.

Global Single-Use Bioprocessing Market Overview

Many end-users view single-use systems (SUS) as an economically feasible strategy to attain the highest level of productivity and process efficiency. SUS equipment is therefore extensively used throughout the biomanufacturing phases, but especially in the production of pre-commercial biopharmaceuticals. Opportunities have been generated for the industry's product providers as a result.

One of the key trends influencing the market for single-use bioprocessing is the growing number of suppliers providing durable disposables for the commercial synthesis of biopharmaceuticals. Big data analytics is expected to be the dominant trend. By enabling prediction and process parameters, the adoption of analytical models based on big data machine learning is projected to increase product yields. Due to the simplicity of use and effectiveness of SUTs in the bioprocessing of several products needing quick turnaround times, CMOs are currently adopting disposables at a significantly greater rate. The market for single-use bioprocessing is heavily influenced by the pharmaceutical industry's expanding need. Because single-use bioprocessing systems can boost process efficiency and lower the expenses involved with sterilizing, cleaning, and maintaining steel bioreactors, the majority of biopharmaceutical businesses are progressively implementing this technology. The single-use bioprocessing system is employed in a variety of biopharmaceutical applications, including mixing, filtering, purification, and storage. The biopharmaceutical industry is also expanding quickly. About 20% of the global pharma market is made up entirely of biopharmaceuticals.

Global Single-Use Bioprocessing Market: Segmentation Analysis

The Global Single-Use Bioprocessing Market is segmented based on Product, Workflow, End Use, And Geography.

Single-Use Bioprocessing Market, By Product

• Containers
• Media bags

Based on the Product, the global single-use bioprocessing market is divided into media bags and containers. In the market, single-use containers are more popular than single-use media bags. During the forecast period, the trend is expected to continue, offering the containers segment a leading market share of the global single-use bioprocessing market.

Single-Use Bioprocessing Market, By Workflow

• Upstream
• Fermentation
• Downstream
• The market is divided into upstream, fermentation, and downstream segments based on workflow. The single-use bioprocessing market is predicted to expand owing to the introduction of a wide array of SUS to be utilized throughout various phases of biomanufacturing. A significant portion of upstream processing has been facilitated by the use of SUS for cell culture, liquid handling, and storage.

Single-Use Bioprocessing Market, By End Use

• Biopharmaceutical Manufacturer
• Academic & Clinical Research Institutes
• Others

Based on End Use, the market is bifurcated into Biopharmaceutical Manufacturer, Academic & Clinical Research Institutes, and Others. The biopharmaceutical manufacturing industry is expected to significantly benefit from the growing popularity of disposables among CMOS. Contract service providers are engaged in the expansion of single-use capacity by installing new Single-Use Bioprocessing products at their facility, thereby aiding in revenue regeneration.

Single-Use Bioprocessing Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
• North America, Europe, Asia Pacific, Latin America (LATAM), the Middle East and Africa are the five main geographic divisions covered in the global single-use bioprocessing market report. The market for single-use bioprocessing is being adopted as a result of the growing need for biopharmaceuticals as well as its benefits, which include quick deployment, minimal risk of product cross-contamination, high energy efficiency, and low water consumption.

Key Players

• The "Global Single-Use Bioprocessing Market" study report will provide valuable insight with an emphasis on the global market. The major players are
• Thermo Fisher Scientific, Merck, Sartorius, Corning Incorporated, Pall Corporation, General Electric, Eppendorf, Rentschler Biopharma, Lonza, Meissner Filtration Products Inc., JM BioConnect, etc.
• The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In March 2020: Danahar acquired the life sciences division of General Electric, Cytiva. Through this acquisition, Danahar is looking to expand its existing life sciences business and obtain a significant market share.
• In September 2020: As a step towards expanding its life science business, Thermo Fisher Scientific did an investment of over 475 million at its St. Louis plant. The investment is mainly focused on carrying out research and development activities in several fields such as gene therapies, drug development, biopharmaceuticals, and biologics.